Cart
Your shopping cart is empty!
It's never too late to make things right :)

Page 9 - Primobolan (metenolone) injections

EU25197
Active substance:Testosterone Propionate Also known as:Methenolone Enanthate Blood pressure:Can cause hypertension in susceptible individuals
In stock
£50.46
Active substance Testosterone Propionate
Also known as Methenolone Enanthate
Blood pressure Can cause hypertension in susceptible individuals
EU20062
Also known as:Methenolone Enanthate Blood pressure:Can cause hypertension in susceptible individuals Chemical name:17ОІ-Hydroxy-1-methyl-5О±-androst-1-en-3-one enanthate
In stock
£41.76
Also known as Methenolone Enanthate
Blood pressure Can cause hypertension in susceptible individuals
Chemical name 17ОІ-Hydroxy-1-methyl-5О±-androst-1-en-3-one enanthate
EU11509
Acne:Yes Active Half-Life:5-7 days Active substance:Methenolone Enanthate
In stock
£167.04
Acne Yes
Active Half-Life 5-7 days
Active substance Methenolone Enanthate
EU20971
Acne:Yes Active Half-Life:5-7 days Active substance:Drostanolone Enanthate, Methenolone Enanthate, Testosterone Enanthate
In stock
£114.84
Acne Yes
Active Half-Life 5-7 days
Active substance Drostanolone Enanthate, Methenolone Enanthate, Testosterone Enanthate
EU10863
Active substance:Human Growth Hormone Also known as:Methenolone Enanthate Blood pressure:Can cause hypertension in susceptible individuals
In stock
£177.48
Active substance Human Growth Hormone
Also known as Methenolone Enanthate
Blood pressure Can cause hypertension in susceptible individuals
EU11750
Acne:Yes Active Half-Life:7-8 days Active substance:Testosterone DecanoateTestosterone IsocaproateTestosterone PhenylpropionateTestosterone Propionate
In stock
£47.85
Acne Yes
Active Half-Life 7-8 days
Active substance Testosterone DecanoateTestosterone IsocaproateTestosterone PhenylpropionateTestosterone Propionate
EU10676
Acne:Yes Active Half-Life:5-7 days Active substance:Methenolone Enanthate
In stock
£109.62
Acne Yes
Active Half-Life 5-7 days
Active substance Methenolone Enanthate

Editorial team
Created: 08/08/2025
Jack Clark
Jack Clark Editor